GLP-1 lekovi za 13 odsto smanjuju rizik od velikih neeljenih kardiovaskularnih dogaaja Pregled 11 glavnih studija kardiovaskularnih ishoda, objavljen u asopisu Cardiovascular Diabetology Endocrinology Reports , pokazao je da je leenje agonistima GLP-1 receptora smanjilo rizik od velikih neeljenih kardiovaskularnih dogaaja, kao to su srani udar, modani udar i kardiovaskularna smrt, za priblino 13 odsto u poreenju sa placebom tokom prosenog praenja od skoro tri godine
Life Sciences 1 min read Torrent Pharma launches oral, injectable semaglutide in India under Sembolic, Semalix The company enters the GLP-1 segment with pricing starting at 3,999 per month, including what it claims is Indias first generic oral version of the drug
Key Research Focus Areas Wound Healing and Tissue Repair Examining GHK-Cus influence on collagen synthesis, extracellular matrix deposition, and accelerated epithelialization in models of acute and chronic wounds
Figure 1B summarizes the neurotrophic pathways affected in tinnitus
Eligibility typically includes individuals with a body mass index (BMI) of 30 or higher , or a BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
In addition to boosting intake, supplementing with magnesium may be helpful for conditions such as migraines and menstrual pain, and it is an effective laxative and antacid
